ArticleJournal of computer-aided molecular design2018

An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant.

Zainab K Sanusi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.